Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Sales (2016 - 2025)

Historic Return on Sales for Mimedx (MDXG) over the last 16 years, with Q2 2025 value amounting to 0.0%.

  • Mimedx's Return on Sales changed 0.0% to 0.0% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.0%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 300.0% up from last year.
  • Per Mimedx's latest filing, its Return on Sales stood at 0.0% for Q2 2025, which was down 0.0% from 0.0% recorded in Q1 2025.
  • Mimedx's Return on Sales' 5-year high stood at 0.13% during Q4 2022, with a 5-year trough of 0.18% in Q1 2022.
  • Moreover, its 5-year median value for Return on Sales was 0.0% (2023), whereas its average is 0.04%.
  • As far as peak fluctuations go, Mimedx's Return on Sales soared by 2600bps in 2021, and later tumbled by -1400bps in 2022.
  • Over the past 5 years, Mimedx's Return on Sales (Quarter) stood at 0.0% in 2021, then soared by 3275bps to 0.13% in 2022, then tumbled by -81bps to 0.03% in 2023, then tumbled by -95bps to 0.0% in 2024, then crashed by -51bps to 0.0% in 2025.
  • Its Return on Sales was 0.0% in Q2 2025, compared to 0.0% in Q1 2025 and 0.0% in Q4 2024.